Stock watch - Borland
Despite industry surprise at Borland's acquisition of Visigenics, the reaction from Wall Street was not favourable as share prices fell $1.50 on the announcement of the deal (see news story, page 28).
Despite industry surprise at Borland's acquisition of Visigenics, the reaction from Wall Street was not favourable as share prices fell $1.50 on the announcement of the deal (see news story, page 28).